STUDIES ON MACROCYCLIC LACTONE ANTIBIOTICS .12. RHIZOXIN BINDING TO TUBULIN AT THE MAYTANSINE-BINDING SITE

被引：121

作者：

TAKAHASHI, M

IWASAKI, S

KOBAYASHI, H

OKUDA, S

MURAI, T

SATO, Y

机构：

[1] UNIV TOKYO,INST APPL MICROBIOL,BUNKYO KU,TOKYO 113,JAPAN

[2] KYORITSU COLL PHARM,TOKYO,JAPAN

来源：

BIOCHIMICA ET BIOPHYSICA ACTA | 1987年 / 926卷 / 03期

关键词：

D O I：

10.1016/0304-4165(87)90206-6

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

引用

页码：215 / 223

页数：9

共 26 条

[1] TUBULIN AGGREGATION AND DISAGGREGATION - MEDIATION BY 2 DISTINCT VINBLASTINE-BINDING SITES [J].

BHATTACHARYYA, B ;

WOLFF, J .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1976, 73 (07) :2375-2378

[2] MAYTANSINE BINDING TO VINBLASTINE SITES OF TUBULIN [J].

BHATTACHARYYA, B ;

WOLFF, J .

FEBS LETTERS, 1977, 75 (01) :159-162

[3]

FELLOUS A, 1985, CANCER RES, V45, P5004

[4]

FRACON J, 1978, EUR J BIOCH, V85, P43

[5] MICROBIOLOGICAL ASSAYS AND BIOAUTOGRAPHY OF MAYTANSINE AND ITS HOMOLOGS [J].

HANKA, LJ ;

BARNETT, MS .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1974, 6 (05) :651-652

[6]

HASHIDA F, 1977, NATURE, V270, P721

[7] STUDIES ON MACROCYCLIC LACTONE ANTIBIOTICS .8. ABSOLUTE STRUCTURES OF RHIZOXIN AND A RELATED COMPOUND [J].

IWASAKI, S ;

NAMIKOSHI, M ;

KOBAYASHI, H ;

FURUKAWA, J ;

OKUDA, S ;

ITAI, A ;

KASUYA, A ;

IITAKA, Y .

JOURNAL OF ANTIBIOTICS, 1986, 39 (03) :424-429

[8] STUDIES ON MACROCYCLIC LACTONE ANTIBIOTICS .7. STRUCTURE OF A PHYTOTOXIN RHIZOXIN PRODUCED BY RHIZOPUS-CHINENSIS [J].

IWASAKI, S ;

KOBAYASHI, H ;

FURUKAWA, J ;

NAMIKOSHI, M ;

OKUDA, S ;

SATO, Z ;

MATSUDA, I ;

NODA, T .

JOURNAL OF ANTIBIOTICS, 1984, 37 (04) :354-362

[9] STUDIES ON MACROCYCLIC LACTONE ANTIBIOTICS .10. BIOSYNTHESIS OF THE ANTIMITOTIC ANTITUMOR ANTIBIOTIC RHIZOXIN BY RHIZOPUS-CHINENSIS - ORIGINS OF THE CARBON-ATOMS [J].

KOBAYASHI, H ;

IWASAKI, S ;

YAMADA, E ;

OKUDA, S .

JOURNAL OF THE CHEMICAL SOCIETY-CHEMICAL COMMUNICATIONS, 1986, (23) :1702-1703

[10]

KRAGHHANSEN U, 1981, PHARMACOL REV, V33, P17

← 1 2 3 →